VIA Pharmaceuticals, Inc.
VIAP
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Net Income | -16.63% | -1.23% | 28.33% | 31.25% | 47.16% |
| Total Depreciation and Amortization | -40.43% | -31.22% | -35.74% | -2.45% | -4.39% |
| Total Amortization of Deferred Charges | 175.40% | 91.84% | 1,769.31% | -99.04% | -77.78% |
| Total Other Non-Cash Items | -134.36% | -51.08% | -42.92% | 78.94% | 6.29% |
| Change in Net Operating Assets | -43.80% | -12.68% | 213.42% | -221.85% | -29.49% |
| Cash from Operations | -15.87% | -9.58% | 68.03% | -22.48% | -3.71% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -13.04% | 91.67% | -52.00% | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -13.04% | 91.25% | -51.87% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -262.12% | 135.28% | 79.97% | 29.53% | -243.36% |